Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation - Concepedia

Concepedia

Publication | Closed Access

Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation

155

Citations

49

References

2018

Year

Yi Li, Haitao Li, Shuai Liu, Pinhua Pan, Xiaoli Su, Hongyi Tan, Dongdong Wu, Lemeng Zhang, Chao Song, Minhui Dai,

Molecular Immunology

InflammationLipopolysaccharide-induced Pulmonary InflammationAntifibrotic TherapyAnti-inflammatoryInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationMedicineImmunologyChronic InflammationNlrp3 Inflammasome ActivationPulmonary PharmacologyPulmonary FibrosisPharmacologyMatrikinesPulmonary Disease

References

	Year	Citations

Page 1

Page 1